Glatiramer Acetate Powder, identified by CAS number 147245-92-9, stands as a crucial pharmaceutical intermediate in the development and manufacturing of medications. Known for its white powder appearance and typically high purity levels, often reaching 99% or above, this compound plays a significant role in the pharmaceutical landscape, particularly within the realm of neurology.

As a complex peptide mixture, Glatiramer Acetate functions uniquely within the body, influencing immune responses. Its primary approved application, according to regulatory bodies like the Food and Drug Administration (FDA), is focused on reducing the frequency of relapses in certain forms of multiple sclerosis (MS). This makes it an indispensable component in the production of therapies aimed at managing this challenging autoimmune disease.

While its proven efficacy lies in relapse reduction, the potential broader impact of Glatiramer Acetate is a subject of ongoing interest. Observational studies have suggested a possible role in mitigating the progression of disability in MS patients. However, it is important to note that this potential benefit has not been conclusively demonstrated in randomized controlled trials, underscoring the distinction between observed trends and statistically proven outcomes.

The production of High Purity Glatiramer Acetate Powder demands stringent quality control and adherence to pharmaceutical standards. Its nature as an intermediate means it undergoes further processing and formulation into final drug products. Therefore, the initial purity and consistency of the powder are paramount to ensuring the safety, efficacy, and stability of the eventual medication. Manufacturers and suppliers of this material must employ robust analytical methods, such as HPLC, to verify purity, molecular weight distribution, and other critical parameters.

Ensuring a reliable supply chain for essential pharmaceutical intermediates like Glatiramer Acetate is vital for global healthcare. Pharmaceutical companies rely on consistent access to high-quality raw materials to maintain production schedules and meet patient needs. The white powder form is convenient for handling, storage (typically in a cool, dry place with a shelf life of around two years), and transportation.

For pharmaceutical developers and manufacturers seeking a dependable source of High Purity 99% Glatiramer Acetate Powder (CAS 147245-92-9), NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated supplier offering this critical intermediate. As a professional manufacturer and supplier in the field of pharmaceutical raw materials, we understand the importance of quality, consistency, and regulatory compliance. Businesses looking to buy or purchase Glatiramer Acetate Powder are encouraged to inquire directly about availability and price. Obtaining samples is often possible to facilitate evaluation and ensure the material meets specific requirements before a larger purchase. Contacting a trusted manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. is the first step in securing a high-quality supply for your pharmaceutical production needs.